We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Reports the immune response to MGAC-007 in myasthenia gravis, suggesting potential therapeutic benefits.
To report the preclinical development of
No takes yet. Share an insight, caveat, or question.
Oved et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: